EARNEST Partners’s Exact Sciences EXAS Stock Holding History

EARNEST Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-64	Closed	-$4.37K	–	554
2023 Q3	$4.37K	Hold	64	–	–	﹤0.01%	835
2023 Q2	$6.01K	Hold	64	–	–	﹤0.01%	753
2023 Q1	$4.34K	Hold	64	–	–	﹤0.01%	829
2022 Q4	$3.17K	Hold	64	–	–	﹤0.01%	911
2022 Q3	$2K	Hold	64	–	–	﹤0.01%	964
2022 Q2	$3K	Hold	64	–	–	﹤0.01%	912
2022 Q1	$4K	Hold	64	–	–	﹤0.01%	886
2021 Q4	$5K	Hold	64	–	–	﹤0.01%	847
2021 Q3	$6K	Hold	64	–	–	﹤0.01%	789
2021 Q2	$8K	Hold	64	–	–	﹤0.01%	716
2021 Q1	$8K	Hold	64	–	–	﹤0.01%	698
2020 Q4	$8K	Hold	64	–	–	﹤0.01%	677
2020 Q3	$7K	Hold	64	–	–	﹤0.01%	651
2020 Q2	$6K	Hold	64	–	–	﹤0.01%	681
2020 Q1	$4K	Hold	64	–	–	﹤0.01%	712
2019 Q4	$6K	Hold	64	–	–	﹤0.01%	710
2019 Q3	$6K	Hold	64	–	–	﹤0.01%	690
2019 Q2	$8K	Hold	64	–	–	﹤0.01%	628
2019 Q1	$6K	Hold	64	–	–	﹤0.01%	682
2018 Q4	$4K	Hold	64	–	–	﹤0.01%	768
2018 Q3	$5K	Hold	64	–	–	﹤0.01%	758
2018 Q2	$4K	Buy	+64	New	+$3.44K	﹤0.01%	834

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

EARNEST Partners's EXAS Position: Q4 2023 in Review

EARNEST Partners sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 64 shares — an estimated $4.37K sold.

EARNEST Partners first reported a position in EXAS in Q2 2018 and held it in 22 quarters. The position peaked at $8K in Q2 2021. 646 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

EARNEST Partners reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
EARNEST Partners sold 64 Exact Sciences shares in Q4 2023, an estimated $4.37K.
EARNEST Partners first reported a position in Exact Sciences in Q2 2018 and held it in 22 quarters.
EARNEST Partners's Exact Sciences position peaked at $8K in Q2 2021.
646 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.